MedTrace Logo

Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer Patients

NCT02965391 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-03-27

No results posted yet for this study

Summary

Previous study showed circulating tumor DNA levels reflect the total systemic tumor burden. Circulating tumor DNA levels should decrease after complete surgery and could be increase as tumor recurrence. Few study investigated the half time of circulating tumor DNA in lung cancer patients that no criterion has been established of how to use it for surveillance.

Conditions

  • Carcinoma
  • Non-small-cell Lung Cancer
  • Lung Neoplasms

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Jun Wang, M.D. · Peking University People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-09-30
Completion
2019-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02965391 on ClinicalTrials.gov